Patents by Inventor Solange G. D'Ambrieres

Solange G. D'Ambrieres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Erythromycin compounds
    Patent number: 5635485
    Abstract: An erythromycin compound of Formula I or its non-toxic acid addition salt having antibiotic activity.
    Type: Grant
    Filed: April 21, 1995
    Date of Patent: June 3, 1997
    Assignee: Roussel Uclaf
    Inventors: Constantin Agouridas, Jean-Francois Chantot, Alexis Denis, Solange G. D'Ambrieres, Odile L. Martret
  • Cephalosporins
    Patent number: 5587372
    Abstract: A syn isomer in (R) or (S) form or a mixture thereof of a compound of the formula ##STR1## syn isomer, in the (R) or (S) form or in the form of an (R,S) mixture, in the form of an internal salt or their salts with organic or mineral acids,wherein the variables are herein below defined, having antibacterial properties.
    Type: Grant
    Filed: December 13, 1993
    Date of Patent: December 24, 1996
    Assignee: Roussel Uclaf
    Inventors: Jozsef Aszodi, Jean-Francois Chantot, Patrick Fauveau, Solange G. D'Ambrieres, Daniel Hunbert, Christophe Dini
  • Cephalosporins
    Patent number: 5541318
    Abstract: A compound selected from the group consisting of a syn isomer of a compound of the formula: ##STR1## in the R or S form or in the form of an R, S mixture wherein the variables are herein below defined, and their non-toxic, pharmaceutically acceptable acid addition salts having anti-bacterial activity.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: July 30, 1996
    Assignee: ROUSSEL UCLAF
    Inventors: Jozsef Aszodi, Jean-Francois Chantot, Solange G. D'Ambrieres
  • Cephalosporins
    Patent number: 5538963
    Abstract: The syn isomer of a compound of the formula ##STR1## in the R or S form or a mixture of R and S forms wherein selected from the group consisting of ##STR2## and their non-toxic, pharmaceutically acceptable acid addition salts wherein the substituents are defined as in the specification having antibacterial activity and their preparation.
    Type: Grant
    Filed: September 27, 1994
    Date of Patent: July 23, 1996
    Assignee: Roussel Uclaf
    Inventors: Jean-Francois Chantot, Solange G. D'Ambrieres, Daniel Humbert, Jean-Georges Teutsch
  • Cephalosporins
    Patent number: 5397779
    Abstract: A compound selected from the group consisting of a syn isomer of a compound of the formula ##STR1## in the R or S form or in the form of an R, S mixture wherein R.sub.1, Rc, Rb, A and A' are defined as in the following specification and their non-toxic, pharmaceutically acceptable acid addition salts having anti-bacterial activity.
    Type: Grant
    Filed: December 7, 1992
    Date of Patent: March 14, 1995
    Assignee: Roussel-Uclaf
    Inventors: Jozsef Aszodi, Jean-Francois Chantot, Solange G. D'Ambrieres
  • Cephalosporins
    Patent number: 5373001
    Abstract: A compound selected from the group consisting of a syn isomer of a compound of the formula ##STR1## in the R or S form or in the form of a R, S mixture wherein the various substituents are defined as in the specification and their non-toxic, pharmaceutically acceptable acid addition salts having anti-bacterial activity.
    Type: Grant
    Filed: July 22, 1993
    Date of Patent: December 13, 1994
    Assignee: Roussel Uclaf
    Inventors: Jozsef Aszodi, Jean-Francois Chantot, Solange G. D'Ambrieres